-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Operating Lease, Payments history and growth rate from 2022 to Q3 2025.
- Mereo BioPharma Group plc Operating Lease, Payments for the quarter ending September 30, 2025 was $203K, a 2.53% increase year-over-year.
- Mereo BioPharma Group plc Operating Lease, Payments for the twelve months ending September 30, 2025 was $800K, a 0.87% decline year-over-year.
- Mereo BioPharma Group plc annual Operating Lease, Payments for 2024 was $780K, a 2.77% increase from 2023.
- Mereo BioPharma Group plc annual Operating Lease, Payments for 2023 was $759K, a 34.2% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)